✦ LIBER ✦

Low dose lenalidomide induction followed by autologous transplantation in untreated patients with myeloma is associated with adequate collection of haematopoietic and dendritic cell precursors and high response rates

✍ Scribed by Khot, A.; Sedunary, R.; Stokes, K.; Loudovaris, M.; Wall, D.; Prince, M.; Ritchie, D.; Harrison, S.

Book ID: 122870152
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 73 KB
Volume: 15
Category: Article
ISSN: 1465-3249
DOI: 10.1016/j.jcyt.2013.01.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and feasibility of CHOP/rituximab

Safety and feasibility of CHOP/rituximab induction treatment followed by high-dose chemo/radiotherapy and autologous PBSC-transplantation in patients with previously untreated mantle cell or indolent B-cell-non-Hodgkin's lymphoma

✍ Heß, G; Flohr, T; Huber, C; Kolbe, K; Derigs, H-G; Fischer, T 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 156 KB

High-dose therapy and autologous periphe

High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients

✍ Massimo Martino; Giuseppe Console; Giuseppe Irrera; Giulia Praticò; Caterina Ste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 2 views

## Abstract The recent development of reduced intensity conditioning and allotransplantation (RICT) has opened a new way to assure engraftment of donor cells while reducing early transplant‐related mortality. We evaluated the combination of high‐dose therapy and autologous peripheral blood stem cel